Interferon-beta offers promising avenues to COVID-19 treatment: a systematic review and meta-analysis of clinical trial studies

Severe acute respiratory syndrome coronavirus 2 principally weakens the hosts’ innate immune system by impairing the interferon function and production. Type I interferons (IFNs) especially IFN-β are best known for their antiviral activities. IFNs accompanied by the standard care protocols have open...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakhlband, Ailar, Fakhari, Ali, Azizi, Hosein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883756/
https://www.ncbi.nlm.nih.gov/pubmed/33587164
http://dx.doi.org/10.1007/s00210-021-02061-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883756/
https://www.ncbi.nlm.nih.gov/pubmed/33587164
http://dx.doi.org/10.1007/s00210-021-02061-x

Ejemplares similares